bioAffinity Technologies (BIAFW) Income from Continuing Operations (2021 - 2026)
bioAffinity Technologies (BIAFW) reported Income from Continuing Operations of 3630610.0 for Q1 2026, down 36.47% year-over-year from 5714589.64 in Q1 2025, and down 15.72% quarter-over-quarter from 3137466.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Income from Continuing Operations (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 6 years of Income from Continuing Operations data on file, last reported at 3630610.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 3630610.0, down 36.47% year-over-year; the trailing twelve-month figure through Mar 2026 was 15879947.0 (down 63.06% YoY), and the FY2025 annual result was 14909754.0, down 64.93% from the prior year.
- Income from Continuing Operations eased to 3630610.0 in Q1 2026 per BIAFW's latest filing, from 3137466.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 88052.0 in Q2 2022 and troughed at 5051084.0 in Q3 2025.
- A 5-year average of 2568901.12 and a median of 2290884.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations soared 69.97% in 2022, then slumped 1876.3% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 1674583.0 in 2022, then slumped by 41.72% to 2373164.0 in 2023, then fell by 25.02% to 2966897.0 in 2024, then fell by 5.75% to 3137466.0 in 2025, then decreased by 15.72% to 3630610.0 in 2026.
- Business Quant data shows BIAFW's Income from Continuing Operations at 3630610.0 in Q1 2026, 3137466.0 in Q4 2025, and 5051084.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | bioAffinity Technologies | - | - | - | -3.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.63 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -5.05 Mn |
| Jun 30, 2025 | -4.06 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | -2.97 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | -2.37 Mn |
| Sep 30, 2023 | -2.29 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | -1.53 Mn |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | -4.92 Mn |
| Jun 30, 2022 | -88,052.00 |
| Mar 31, 2022 | -1.47 Mn |
| Dec 31, 2021 | -5.58 Mn |
| Sep 30, 2021 | -1.51 Mn |